STAT
MARCH 20, 2025
TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical. In a recent filing with the Securities and Exchange Commission, Zynex revealed that the government payer — which represents up to a quarter of Zynex’s annual revenue — was suspending payments as it reviewed prior claims.
Express Pharma
MARCH 20, 2025
Eli Lilly and Company (India) announced the launch of Mounjaro in single-dose vial presentation following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 20, 2025
NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being prescribed. Yet both he and University of Pennsylvania researcher Kiran Musunuru are forging ahead, using contrasting approaches, as they explained onstage at STAT’s Breakthrough Summit East.
Drug Patent Watch
MARCH 20, 2025
Unlock the Full Potential of Your Pharmaceutical Product: The Power of a CDMO As a pharmaceutical professional, you're constantly looking for ways to bring innovative products to market faster and more efficiently. One key strategy that can help you achieve this goal is partnering with a Contract Development and Manufacturing Organization (CDMO). But what exactly is a CDMO, and how can it benefit your business?
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
MARCH 20, 2025
Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
Pharma Marketing Network
MARCH 20, 2025
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
MARCH 20, 2025
The National Health Service (NHS) in England has approved Gedeon Richters Ryeqo, the first long-term pill available for endometriosis for patients who have exhausted all other treatment options. The approval addresses the long-standing gap in long-term treatment options for endometriosis, improving overall disease management while easing the burden on healthcare resources, says GlobalData.
STAT
MARCH 20, 2025
NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of the company — said he was confident in the company’s obesity plans and shed light on why he joined the pharmaceutical giant. Andrew Baum was managing director of equity research at Citigroup until last May, when Pfizer announced that he would take on the role of chief strategy and innovation officer.
Pharma Marketing Network
MARCH 20, 2025
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?
STAT
MARCH 20, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. A panel of experts at a leading speciality society announced in a new clinical guideline that they have decided not to decide whether to recommend AI-assisted colonoscopies.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Script
MARCH 20, 2025
Are you butting heads with your colleagues? Our team at Rx relief describes three conflict resolution tactics you should implement.
STAT
MARCH 20, 2025
The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer concerns over cost and a lack of patient adherence remain stubborn obstacles to wider adoption, a pair of health executives explained Thursday. The medicines have proven wildly popular and, in turn, have generated huge sales, long stretches of shortages, and unchecked excitement among investors.
The Pharmacist
MARCH 20, 2025
Pharmacy leaders have expressed hope that the long awaited pharmacy contract will include an uplift to cover increased National Insurance Contributions (NICs), after MPs voted yesterday against exempting pharmacy employers from the measure. Last month, peers in the House of Lords voted to freeze NICs for primary care employersat 13.8%. This would have seen them […] The post Hopes pharmacy contract will include NI uplift after 'disappointing' MPs vote appeared first on The Pharmac
STAT
MARCH 20, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Happy “Severance” finale day to all who celebrate.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Drug Patent Watch
MARCH 20, 2025
Navigating the Complex World of Biosimilar Regulatory Agency Interactions As a biosimilar developer, you know that getting your product to market can be a long and arduous process. One of the most critical components of this journey is interacting with regulatory agencies. But how can you ensure that these interactions are effective and set your product up for success?
The Pharmacist
MARCH 20, 2025
The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of suicidality as previously suggested, an analysis of UK data has found. A study comparing GP records of patients taking GLP-1RA drugs and those taking dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT2) inhibitors found […] The post Semaglutide not associated with increased risk of suicide, say researchers appeared first on The Pharmacist
Pharmaceutical Technology
MARCH 20, 2025
OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
Pharmaceutical Business Review
MARCH 20, 2025
This collaboration leverages Porton Advanced’s cell and gene therapy manufacturing offerings and Artemiscell receptor as well as the EALPHAantibody discovery platforms of Eureka. Through this partnership, Porton Advanced will provide CAR-T manufacturing services for investigator-initiated trials (IITs) of Eureka, ensuring compliance with quality standards.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The Pharmacist
MARCH 20, 2025
The final version of the economic analysis of community pharmacy report has been shared with Community Pharmacy England (CPE) and other stakeholders, it has been confirmed. But the highly anticipated report will not be published before the pharmacy contract talks finish, NHS England (NHSE) has stressed. NHSEs national director for primary care and community service, […] The post 'Final version' of pharmacy economic review shared with CPE appeared first on The Pharmacist.
Pharmaceutical Technology
MARCH 20, 2025
Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.
Safe Biologics
MARCH 20, 2025
A recent IQVIA report funded by the generics industry trade group Association for Accessible Medicines is propagating several misleading claims about interchangeable biosimilars. ASBM has frequently addressed misinformation efforts about interchangeablity biosimilars in recent months, to correct the record and reinforce the rigorous FDA standards now protecting patient safety and treatment stability.
pharmaphorum
MARCH 20, 2025
A study has suggested early targeting of amyloid in the brains of people with inherited Alzheimer's can delay symptoms, but not all are convinced.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
World Pharma News
MARCH 20, 2025
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078). Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialise petrelintide, Zealand Pharma's amylin analog as a standalone therapy as well as a fixed-dose combination with Roches lead incretin asset CT-388.
Pharmaceutical Commerce
MARCH 20, 2025
Jonathan James, CEO, Hope Charities, discusses the critical importance of maintaining access to life-saving medications for patients with rare diseases to lead productive lives.
BioPharma Dive
MARCH 20, 2025
To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as Zolgensma, could be approved for a broad range of spinal muscular atrophy patients.
Pharma Times
MARCH 20, 2025
The update is aimed at strengthening local and national surveillance
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
BioPharma Dive
MARCH 20, 2025
The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs aiming to “reset” the immune systems of people with inflammatory conditions.
pharmaphorum
MARCH 20, 2025
Brain-computer interface specialist Synchron has previewed an AI model that it believes will form the basis of a new generation of devices.
Pharmacy Times
MARCH 20, 2025
Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care.
pharmaphorum
MARCH 20, 2025
UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
302 
Let's personalize your content